High expression of FGF19 is not only associated with increased clonogenicity and stem cell-like properties of GBM cells, but also with enhanced tumor invasiveness, mediated by alterations in cell adhesion and activation of the integrin signaling pathway via FGFR4. The gene discussed is FGF19; the disease is neoplasm.